CIDRAP newsletters options
Vaccine effectiveness was 44% for the H1N1 strain but essentially zero for H3N2.
A study yesterday in the Proceedings of the National Academy of Sciences describes the unique emergence of the pandemic multidrug-resistant Escherichia coli clone ST1193.
High activity has returned to the towns and villages where the outbreak began 11 months ago.
The median number of days for hospitals to start using any of 6 new antimicrobials was 398.
With 18 more infections recorded in the last week, the United States has seen 1,095 measles cases in 2019—the most cases in the United States since 1992 and since measles was declared eliminated in 2000.
A multidisciplinary, multifaceted intervention aimed at targeting health professionals' and patients' attitudes regarding antibiotic use helped improve outpatient antibiotic prescribing at Portuguese primary care clinics, a team of Portuguese researchers reported yesterday in the Journal of Antimicrobial Chemotherapy.
"It is important to break the vicious cycle," a top WHO official says.
Viruses account for 61.4% of cases in young kids, with RSV the most common viral cause and the leading cause of severe pneumonia.
The Democratic Republic of the Congo (DRC) has reported two more outbreaks of circulating vaccine-derived poliovirus type 2 (cVDPV2), according to the latest update from the Global Polio Eradication Initiative (GPEI). The GPEI today detailed 10 new polio cases in four countries, as well as cVDPV2 in a healthy case contact.
A survey of Japanese dentists indicates that attitudes toward antimicrobial prophylaxis vary widely, with many reporting going against current guidelines, Japanese researchers reported today in a letter in Infection Control and Hospital Epidemiology.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Data on 60 million people indicate the vaccine has slashed infections and pre-cancer lesions.
A USAID official says 4 major donors have jump-started a new "strategic plan.'
The number of Cryptosporidium outbreaks, which occur most commonly in the summer, has risen about 13% each year from 2009 to 2017, according to a new report from the US Centers for Disease Control and Prevention (CDC) published today in Morbidity and Mortality Weekly Report (MMWR).
Cases rise steadily ahead of a meeting to consider use of a second Ebola vaccine.
A new multicenter study today in Clinical Infectious Diseases found little effect of ribavirin and interferon therapy on critically ill MERS patients.
The study took place from 2012 to 2018 at 14 Saudi Arabian hospitals, and involved 349 Middle East respiratory syndrome coronavirus (MERS-CoV) patients seeking treatment in intensive care units (ICUs).
A meta-analysis of 12 studies indicates that serum procalcitonin levels are unlikely to help clinicians determine whether community-acquired pneumonia (CAP) in adults requires antibiotics, researchers from Baylor College of Medicine reported yesterday in Clinical Infectious Diseases.
In the past 10 days, officials have recorded nearly 100 new cases, and the outbreak has reached 2,265 infections.
To control the deadly fungus, scientists have to better understand how it spreads.
President Trump yesterday signed bipartisan legislation reauthorizing the Pandemic and All-Hazards Preparedness and Advancing Innovations Act (PAHPA), which plays a crucial role in preparing the country for natural or manmade biological threats such as pandemic flu or a bioterror attack.
